Abstract
One hundred and eighty-seven strains of Cryptococcus neoformans isolated from patients in Thailand were charcterized by biochemical varieties relating to serogroups. Canavanine-glycine-bromothymol blue (CGB) agar was used for differentiating the varieties of C. neoformans. Slide agglutination tests were performed with Crypto Check (Iatron, Inc., Tokyo) to determine their serotypes. Fifty-five percent (10 out of 18) of the pre-AIDS isolates were serotype B, 28% were serotype A, 5% were serotype D, and an unexpected 11% (2 out of 18) were serotype C. These are the first to be recorded in Asia. In contrast, among the 169 clinical isolates obtained between January 1993 and March 1995 (AIDS epidemic), serotype A was outstandingly predominant-93% (157 out of 169), serotype B was relatively low (3.6%) and both serotypes D and AD were 1.8%. The pattern of serotypes of the 59 isolates from known HIV-positive patients was closely similar to the total isolates during the AIDS epidemic. In determining the varieties of C. neoformans by CGB, only 1 of the 187 isolates gave a false reaction. On the basis of our findings, we believe that in the pre-AIDS era either C. neoformans var. gattii serorype B or serotype C were the common causative agents of cryptococcosis in Thailand. The advent of AIDS changed the pattern of serotypes with serotype A becoming predominant as has been reported world wide.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Imwidthaya P. One year's experience with Cryptococcus neoformans in Thailand. Trans Royal Soc Trop Med Hyg 1994; 88: 208.
Evans EE. The antigenic composition of Cryptococcus neoformans, I: Serologic classification by means of the capsular and agglutination reactions. J Immunol 1951; 67: 109–114.
Wilson DE, Bennett JE, Bailley JW. Serologic grouping of Cryptococcus neoformans. Proc Soc Exp Biol Med 1968; 127: 820–823.
Ikeda R, Shinoda T, Fukazawa Y, Kaufman L. Antigenic characterization of Cryptococcus neoformans serotypes and its application to serotyping of clinical isolates. J Clin Microbiol 1982; 16: 22–29.
Kwon-Chung KJ, Bennett JE, Theodore TS. Cryptoccus bacillisporus sp. nov. serotype B-C of Cryptococcus neoformans. Int J System Bact 1978; 28: 616–620.
Kwon-Chung KJ, Polacheck I, Bennett JE. Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotype A and D) and Cryptococcus neoformans var. gattii (serotypes B and C). J Clin Microbiol 1982; 15: 535–537.
Bennett JE, Kwon-Chung KJ, Howard DH. Epidemiologic differences among serotypes of Cryptococcus neoformans. Am J Epidemiol 1977; 195: 582–586.
Kwon-Chung KJ, Bennett JE. Epidemiological differences between the two varieties of Cryptococcus neoformans. Am J Epidemiol 1984; 120: 123–130.
Kwon-Chung KJ, Bennett JE. High prevalence of Cryptococcus neoformans var. gattii in tropical and subtropical regions. Zbl Bakt Hyg 1984; 1A 257: 213–218.
Kwon-Chung KJ, Bennett JE. Medical Mycology, Philadelphia: Lea & Febiger. 1992; 66–67.
Kreger-van Rij, NJW. The Yeasts. Amsterdam: Elsevier. 1984; 45–103, 467–482.
Gordon PC, Clark KA, Milliman C, Majlessi M, Talbot A, Pusateri KD. Development of rapid nonisotonic DNA probe assays for fungi: Cryptococcus neoformans. Abstr Gen Meet Am Soc Microbiol 1991; F81: 422.
Kabasawa K, Itagaki H, Ikeda R, Shinoda T, Kagaya K, Fukazawa Y. Evaluation of a new method for identification of Cryptococcus neoformans which uses serologic tests aided by selected biologic tests. J Clin Microbiol 1991; 29: 2873–2876.
Ellis DH, Pfeiffer TJ. Natural habitat of Cryptococcus neoformans var. gattii. J Clin Microbiol 1990; 28: 1642–1644.
Ellis DH. Cryptococcus neoformans var. gattii. Austral J Clin Microbiol 1987; 25: 430–431.
Levitz SM. The ecology of Cryptococcus neoformans and epidemiology of cryptococcosis. Rev Infect Dis 1991; 13: 1163–1169.
Swinne D, Nkurikiyinfura JB, Muyembe TL. Clinical isolates of Cryptococcus neoformans from Zaire. Eur J Clin Microbiol 1986; 5: 50–51.
Rinaldi MG, Drutz DJ, Howell A, Sande MA, Wofsy CB, Hadley WK. Serotypes of Cryptococcus neoformans in patients with AIDS (letter). J Infect Dis 1986; 153: 642.
Shimizu RY, Howard DH, Clancy MN. The variety of Cryptococcus neoformans in patients with AIDS (letter). J Infect Dis 1986; 154: 1042.
Bottone EJ, Salkin IF, Hurd NJ, Wolmser GP. Serogroup distribution of Cryptococcus neoformans in patients with AIDS (letter). J Infect Dis 1987 156: 242.
Dismukes WE. Cryptococcal meningitis in patients with AIDS. J Infect Dis 1988; 157: 624–628.
Pettoello-Mantovani M, Casadevall A, Kollmann TR, Rubinstein A, Goldstein H. Enhancement of HIV-1 infection by the capsular polysaccharide of Cryptococcus neoformans. Lancet 1992; 393: 21–23.
Pettoello-Mantovani M, Casadevall A, Smarnworawong P, Goldstein H. Enhancement of HIV type 1 infectivity in vitro by capsular polysaccharide of Cryptococcus neoformans and Haemophilus influenzae. AIDS Res Hum Retroviruses 1994; 10: 1079–1087.
Dramer F, Valma A, Ronin O, Mathoulin S, Dupont B. Molecular typing of Cryptococcus neoformans serotype D clinical isolates. J Clin Microbiol 1994; 32: 2364–2371.
Kwon-Chung KJ, Wickes BL, Stockman L, Roberts GD, Ellis DH, Howard DH. Virulence, serotype and molecular characteristics of environmental strains of Cryptococcus neoformans var. gattii. Infect Immunol 1992; 60: 1869–1874.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sukroongreung, S., Nilakul, C., Ruangsomboon, O. et al. Serotypes of Cryptococcus neoformans isolated from patients prior to and during the AIDS era in Thailand. Mycopathologia 135, 75–78 (1996). https://doi.org/10.1007/BF00436454
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00436454